Akèy › Kansè pwostat › Washington
Etid klinik pou Kansè pwostat nan Washington
53 etid pou Kansè pwostat ap chèche patisipan nan sit nan Washington.
Vil nan Washington
- Seattle44 etid
- Tacoma11 etid
- Spokane Valley9 etid
- Kirkland7 etid
- Spokane6 etid
- Renton5 etid
- Bellingham5 etid
- Everett4 etid
- Kennewick4 etid
- Vancouver4 etid
- Longview4 etid
- Walla Walla4 etid
Tèks ofisyèl etid la (Anglè)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Valley Medical Center, Renton
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Swedish Medical Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- University of Washington, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Gason · Mizajou Sep 28, 2026 · NCT04706663Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Research Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06801236A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07082920A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Spokane Urology ( Site 0035), Spokane
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Northwest Medical Specialties, PLLC, Bonney Lake
- Northwest Medical Specialties, PLLC, Federal Way
- Northwest Medical Specialties, PLLC, Gig Harbor
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Fred Hutchinson Cancer Research Center, Seattle
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Swedish Medical Center, Seattle
- Northwest Medical Specialties, Tacoma
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Northwest Medical Specialties, PLLC, Tacoma
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04585750PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- University of Washington Medical Center, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT04995198The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- University of Washington, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Swedish Cancer Institute-Edmonds, Edmonds
- Swedish Medical Center-First Hill, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06632977Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Swedish Cancer Institute-Edmonds, Edmonds
- Swedish Medical Center-First Hill, Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 2, 2026 · NCT07200830The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- ak 19 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069Prostate Active Surveillance Study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou Sep 2, 2026 · NCT00756665Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 27, 2026 · NCT07698535AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Tacoma
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 26, 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 25, 2026 · NCT05593497Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Washington Medical Center, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 24, 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT06844383Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- ak 19 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
- Northwest Medical Specialties, PLLC - Tacoma, Tacoma
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 14, 2026 · NCT04812366Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 12, 2026 · NCT04489719Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 11, 2026 · NCT06236139A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Aug 6, 2026 · NCT01050504Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 2
Tout laj · Gason · Mizajou Aug 6, 2026 · NCT06145633Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 31, 2026 · NCT06613100Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jul 21, 2026 · NCT06039371Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jul 15, 2026 · NCT05918263Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.